As of 2025-03-17, the Relative Valuation of Iteos Therapeutics Inc (ITOS) is (133.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.32 USD, the upside of Iteos Therapeutics Inc based on Relative Valuation is -1919.9%.
The range of the Relative Valuation is (110.23) - (142.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.3x - 49.9x | 41.2x |
| Forward P/E multiples | 26.9x - 40.5x | 34.5x |
| Fair Price | (110.23) - (142.54) | (133.22) |
| Upside | -1605.9% - -2047.3% | -1919.9% |
| Date | P/E |
| 2025-03-04 | -1.94 |
| 2025-03-03 | -1.99 |
| 2025-02-28 | -2.06 |
| 2025-02-27 | -1.99 |
| 2025-02-26 | -2.01 |
| 2025-02-25 | -1.98 |
| 2025-02-24 | -2.08 |
| 2025-02-21 | -2.11 |
| 2025-02-20 | -2.13 |
| 2025-02-19 | -2.13 |
| 2025-02-18 | -2.11 |
| 2025-02-14 | -2.10 |
| 2025-02-13 | -2.07 |
| 2025-02-12 | -2.07 |
| 2025-02-11 | -2.04 |
| 2025-02-10 | -2.04 |
| 2025-02-07 | -2.16 |
| 2025-02-06 | -2.21 |
| 2025-02-05 | -2.22 |
| 2025-02-04 | -2.13 |
| 2025-02-03 | -2.09 |
| 2025-01-31 | -2.14 |
| 2025-01-30 | -2.18 |
| 2025-01-29 | -2.13 |
| 2025-01-28 | -2.13 |
| 2025-01-27 | -2.14 |
| 2025-01-24 | -2.17 |
| 2025-01-23 | -2.18 |
| 2025-01-22 | -2.19 |
| 2025-01-21 | -2.29 |
| 2025-01-17 | -2.27 |
| 2025-01-16 | -2.20 |
| 2025-01-15 | -2.21 |
| 2025-01-14 | -2.18 |
| 2025-01-13 | -2.22 |
| 2025-01-10 | -2.20 |
| 2025-01-08 | -2.22 |
| 2025-01-07 | -2.22 |
| 2025-01-06 | -2.29 |
| 2025-01-03 | -2.32 |
| 2025-01-02 | -2.24 |
| 2024-12-31 | -2.18 |
| 2024-12-30 | -2.07 |
| 2024-12-27 | -2.08 |
| 2024-12-26 | -2.10 |
| 2024-12-24 | -2.12 |
| 2024-12-23 | -2.09 |
| 2024-12-20 | -2.11 |
| 2024-12-19 | -2.05 |
| 2024-12-18 | -2.06 |